why choose us

First received: July 21, 2022

Clinical Trial: Safety of Intravenous Apramycin in Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: Bacterial Infection

Study Type: INTERVENTIONAL


Official Title: A Phase I, Open-label Study to Assess Lung Pharmacokinetics and Safety of a Single Dose of Apramycin Administered Intravenously in Healthy Adult Subjects

Brief Summary: A Phase I, open label study of a single dose of 30 mg/kg of apramycin administered intravenously (IV) over 30 (+/- 5) minutes.Twenty subjects will be enrolled in the study to one of 5 cohorts, T1-T5, each corresponding to a timepoint after initiation of infusion at which a single fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) is performed.There will be 4 subjects per cohort.Cohort T5 will be enrolled after plasma and lung apramycin concentrations and preliminary PK data analysis are completed…

Read more